Advertisement Daiichi Sankyo names new CEO - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Daiichi Sankyo names new CEO

Daiichi Sankyo has named John Gargiulo as the new president and CEO, with immediate effect.

Prior to Daiichi Sankyo, Gargiulo worked as the senior vice president of Commercial Operations where he was responsible for the company’s US marketing, Supply Chain, Managed Markets and New Product Planning.

Daiichi Sankyo former and CEO Joseph Pieroni said John’s experiences within the pharmaceutical industry for the past 25 years havs prepared him well for his new role and responsibility.

"He has been instrumental in building and shaping the company since its inception in 1996, and has touched nearly every aspect of our business operations," Pieroni said.